Tag: Biotechnologies

Biotechnology is the use of living systems and organisms to develop or make products, or “any technological application that uses biological systems, living organisms, or derivatives thereof, to make or modify products or processes for specific use”. Depending on the tools and applications, it often overlaps with the (related) fields of bioengineering, biomedical engineering, biomanufacturing, molecular engineering, etc.

New Biotechnology Company Launched by GT Healthcare

GT Apeiron Therapeutics, a novel biotechnology company, was launched with the backing from GT Healthcare and associated investors. The company also entered into a drug discovery collaboration with ...

Novel and First-in-Cass Drug Design Technology

Cyclica, a leading biotechnology company that commercialized Ligand Express announced its novel, first-in-class drug design technology, Ligand Design on stage at the Collision Conference in Toronto. ...

GeoVax and Leidos to Develop Malaria Vaccine Candidates

GeoVax Labs, Inc., a biotechnology company developing human vaccines, announced today that it has expanded its collaboration activities with Leidos, Inc. to develop malaria vaccine candidates. The wor...

Anixa, Wistar Institute and Dmitry I. Gabrilovich Focus on MDSC

Anixa Biosciences, Inc., a biotechnology company focused on using the body's immune system to fight cancer, today announced it has extended its collaboration with The Wistar Institute and Dmitry I. Ga...

Abilita Bio and Amgen in Multi-Target Research Team

Abilita Bio, Inc. announced that it has entered into a multi-target research collaboration agreement with Amgen, a world leader in biotechnology. Under the terms of the agreement, Abilita Bio will lev...

WuXi and Amicus are into Exclusive Manufacturing Partnership

WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and Amicus Therapeutics, a glob...

Grey Wolf to Fund Development of Therapy Increasing Tumour Visibility

Grey Wolf targets ERAP antigen presentation pathways with the aim of ‘illuminating’ non-responsive tumours for attack and destruction by the immune system. Grey Wolf Therapeutics, a drug discovery ...

Launch of Company Focusing on Preventing Cancer Metastasis

HiberCell, a biotechnology company developing therapeutics focused on preventing cancer relapse and metastasis, launched on February 8 with $60.75M in Series A funding led by ARCH Venture Partners. Hi...

Korean Company Announces Publication of Patent Application

IntoCell, Inc., a Korea-based biotechnology company dedicated to the development and commercialisation of novel antibody drug conjugate (ADC) platform technologies, today announced the publication of ...

B-MoGen and CytoSen to Develop NK Therapies

B-MoGen Biotechnologies, Inc. and CytoSen Therapeutics announced today a research collaboration to develop the next generation of gene-modified Natural Killer Cell (NK) therapies. B-MoGen will utilize...

Russian scientists developed new method of cancer diagnosis

Research teams of Sechenov University have found out a new way to diagnose cancer diseases using a single drop of blood.

India and Cuba aimed to enhance cooperation in biotech and pharma industries

India and Cuba identified new sectors for bilateral cooperation during the recent Havana International Fair, one of the most representative business events in Latin America and the Caribbean.

Allele Biotech produced six iPSCs lines

San Diego-based company produces induced pluripotent stem cells with cGMP control from donors. After three years of cleanroom construction and two years of quality system establishment, Allele Biot...

Abzena enhances its integrated biologic solution

Abzena has augmented existing discovery to GMP drug substance and ADC manufacturing and associated analytical services with investments in preformulation and formulation capabilities.

Five Russian startups present their projects at Cambridge Biomedical Campus

The winners of the Startup Challenge accelerator, organised jointly by the Skolkovo Foundation and AstraZeneca, are showcasing their inventions at the International Future Healthcare Forum.

FUJIFILM Diosynth Biotechnologies receives investment for its bioscience campus

A £7 million (approximately €7,9 million) investment into FUJIFILM Diosynth Biotechnologies facility has been agreed by the local authorities of Tees Valley (UK).